AKT PHOSPHORYLATION AT SER473 AS AN INDICATOR FOR TAXANE-BASED CHEMOTHERAPY
US Application 14/031,699
Filed on 2013-09-19
Filed on 2013-09-19
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
Japan
2014-503673
Filed on 2013-10-03
2014-503673
Filed on 2013-10-03
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
European Patent
12710856.1
Filed on 2012-03-21
12710856.1
Filed on 2012-03-21
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
China
201280027682.4
Filed on 2013-12-05
201280027682.4
Filed on 2013-12-05
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
Australia
2012240562
Filed on 2012-03-21
2012240562
Filed on 2012-03-21
DEFENSIN-ANTIGEN FUSION PROTEINS
US Patent 8,754,030
Filed on 2013-09-09
Filed on 2013-09-09
Photosensitizing Antibody-Fluorophore Conjugates
US Patent 10,538,590
Filed on 2013-08-21
Filed on 2013-08-21
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3
Patent Cooperation Treaty
PCT/US2013/059608
Filed on 2013-09-13
PCT/US2013/059608
Filed on 2013-09-13